ArticlesPodcastsBrandsAbout
Company

Bivision Pharmaceuticals

晶核生物

Bivision PharmaceuticalsCompany
晶核生物
渲染中…
Mentioned in 6 articles

Coverage

  • Interview with RayzeBio: Two Funding Rounds in Six Months, How the Surging "Radiopharma" Sector Is Transforming Cancer Treatment | Gaorong Ventures

    Interview with RayzeBio: Two Funding Rounds in Six Months, How the Surging "Radiopharma" Sector Is Transforming Cancer Treatment | Gaorong Ventures

    Accelerating on the "fast track" of TRT therapy.

    高榕创投·January 17, 2025
  • Rongbao | Embodied intelligence, chips accelerate commercial rollout and R&D; AI transforms creative industries, finance, and more

    Rongbao | Embodied intelligence, chips accelerate commercial rollout and R&D; AI transforms creative industries, finance, and more

    Several companies made it onto the annual lists by *China Entrepreneur* and *Fortune*.

    高榕创投·September 10, 2024
  • CoreVision Biopharma Closes Series A to Accelerate Global Clinical Development of Targeted Radiopharmaceuticals

    CoreVision Biopharma Closes Series A to Accelerate Global Clinical Development of Targeted Radiopharmaceuticals

    Advancing a BIC/FIC dual-driven pipeline with a global perspective.

    高榕创投·July 26, 2024
  • Cutting-edge tech accelerates scaled commercial deployment; AI creates entirely new virtual-world experiences | Rongbao · March

    Cutting-edge tech accelerates scaled commercial deployment; AI creates entirely new virtual-world experiences | Rongbao · March

    The Vitality of Spring.

    高榕创投·April 6, 2023
  • Robotics, SaaS, and innovative drug sectors close new funding rounds; chips and medical devices unveil major new products | Rongbao · August

    Robotics, SaaS, and innovative drug sectors close new funding rounds; chips and medical devices unveil major new products | Rongbao · August

    Differentiated innovation and global opportunities.

    高榕创投·September 6, 2022
  • CoreVision Biopharma Closes Nearly RMB 100 Million Angel Round, Pioneering Visualized Theranostic Targeted Radiopharmaceuticals

    CoreVision Biopharma Closes Nearly RMB 100 Million Angel Round, Pioneering Visualized Theranostic Targeted Radiopharmaceuticals

    Dedicated to becoming a trailblazer in China's TRT space.

    高榕创投·August 10, 2022
© 2025–2026 Elsewhere News LimitedPowered by Kimi
AboutTermsPrivacyStudio